Ozempic and Wegovy have ushered in a rapidly expanding field of obesity drugs, with pharma firms big and small eager to cash in on the massive weight loss drug windfall Other drug candidates in mid-stage development for obesity include Viking Therapeutics VK2735, Structure Therapeutics GSBR-1290 and Altimmunes pemvidutide, Pfizers danuglipron, Amgens AMG133, also known as MariTide, and Roches CT-996 and CT-388
International Journal of Peptide Research and Therapeutics , 29 (4)
BPC-157 is one of the most widely studied peptides for its potential role in supporting recovery , tissue repair , and overall cellular resilience
GHK-Cu as a multifunctional copper peptide: synthesis routes, process engineering and emerging applications
The following table summarizes the evidence landscape honestly, tier by tier